Clay Northam Wealth Management, LLC Ardelyx, Inc. Transaction History
Clay Northam Wealth Management, LLC
- $130 Million
- Q2 2024
A detailed history of Clay Northam Wealth Management, LLC transactions in Ardelyx, Inc. stock. As of the latest transaction made, Clay Northam Wealth Management, LLC holds 232,377 shares of ARDX stock, worth $1.3 Million. This represents 1.32% of its overall portfolio holdings.
Number of Shares
232,377
Previous 91,232
154.71%
Holding current value
$1.3 Million
Previous $665,000
158.8%
% of portfolio
1.32%
Previous 0.54%
Shares
3 transactions
Others Institutions Holding ARDX
# of Institutions
209Shares Held
144MCall Options Held
1.01MPut Options Held
1.43M-
Janus Henderson Group PLC London, X025.9MShares$145 Million0.11% of portfolio
-
Black Rock Inc. New York, NY17.6MShares$98.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.7MShares$76.5 Million0.0% of portfolio
-
State Street Corp Boston, MA12MShares$67 Million0.0% of portfolio
-
Macquarie Group LTD Australia, C36.9MShares$38.6 Million0.06% of portfolio
About ARDELYX, INC.
- Ticker ARDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 154,636,000
- Market Cap $866M
- Description
- Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...